Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $121.55 | Total: $607.75 |
| 1 | 10 | $102.96 | Total: $1,029.60 |
| 1 | 25 | $87.23 | Total: $2,180.75 |
| 1 | 50 | $74.36 | Total: $3,718.00 |
| 1 | 100 | $64.35 | Total: $6,435.00 |
Overview
SBP-3264 is a novel inhibitor of serinethreonine-protein kinases 3 and 4 (STK3 and STK4).
Chemical Properties
| Molecular Formula | C19H20ClN5O |
| Molecular Weight | 369.85 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC(=O)NC1CCN(CC1)c1ncnc2[nH]cc(-c3cccc(Cl)c3)c12 |
Storage and Handling
0C Short Term, -20C Long Term
References
Nicole Bata, et al. Inhibitors of the Hippo Pathway Kinases STK3MST2 and STK4MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. J Med Chem. 2022 Jan 27;65[2] 1352-1369. Letters in Drug Design & Discovery [2014], 11[9], 1119-1123.